16/08/2025
Researchers from the University of Sydney and the Liverpool School of Tropical Medicine have identified heparin an inexpensive, widely available drug as a potential antidote for cobra venom. Using CRISPR gene-editing, they found venom targets enzymes linked to heparan and heparin, enabling it to bind and cause severe tissue necrosis. Administering heparin or related drugs acts as a “decoy,” blocking the toxins and preventing local damage in human cells and mice. Unlike costly antivenoms that often fail to stop tissue destruction, this method directly halts necrosis, potentially preserving limbs. With snakebites killing up to 138,000 people annually, this breakthrough could be rapidly deployed in high-risk regions if human trials confirm its safety and effectiveness.
Atiq Rehman Official 😍🤔😲
Researchers from the University of Sydney and the Liverpool School of Tropical Medicine have identified heparin an inexpensive, widely available drug as a potential antidote for cobra venom. Using CRISPR gene-editing, they found venom targets enzymes linked to heparan and heparin, enabling it to bind and cause severe tissue necrosis. Administering heparin or related drugs acts as a “decoy,” blocking the toxins and preventing local damage in human cells and mice. Unlike costly antivenoms that often fail to stop tissue destruction, this method directly halts necrosis, potentially preserving limbs. With snakebites killing up to 138,000 people annually, this breakthrough could be rapidly deployed in high-risk regions if human trials confirm its safety and effectiveness.
Atiq Rehman Official 😍🤔😲
